Performance characteristics of non-invasive glucose monitoring device prototypes (RSP-16)

Aim of the study

‍Evaluation and comparison of investigational non-invasive glucose monitoring prototypes and assessment of their safe use in extended home-based monitoring.  

Evaluation of the performance and safety assessment of the P0.2 investigational non-invasive glucose monitoring prototype during extended home use.

‍

Study description

‍The 24 participants used the device either during short, intensive measurement days (5 days for 10 hours a day) or at home over several months to assess both short-term performance and long-term stability. Device measurements were compared with standard glucose measurements, all collected while participants followed their normal daily routines.

‍

Conclusions

‍The P0.2 prototype showed stable performance and no safety concerns during extended home use, supporting its suitability for longer-term outpatient monitoring.

Study registration

‍For more information, see the study registration on ClinicalTrials.gov (NCT04021251).

About the study

Study period: December 2018 to April 2021

Prototype ID: P0.2 (redesigned optical model)  

Comparator: FreeStyle Libre (CGM); Contour Next One (BGM)  

Site: Steno Diabetes Center Odense, Denmark  

No of participants: 24  

Profile of participants: Adults with diabetes of all types

Study days: 5 out-patient days or 90 out-patient days